179 related articles for article (PubMed ID: 32011062)
1. The role of allogeneic hematopoietic stem cell transplantation and Epstein-Barr virus infection on the treatment for child primary hemophagocytic lymphohistiocytosis patients with X-linked lymphoproliferative disease: A rare case report and family survey study.
Cui T; Wang Y; Wang J; Zhang J; Gao Z; Wang Z
Pediatr Transplant; 2020 Jun; 24(4):e13635. PubMed ID: 32011062
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
4. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
6. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
7. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
8. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
[TBL] [Abstract][Full Text] [Related]
9. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
[TBL] [Abstract][Full Text] [Related]
10. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation.
Weber T; Wickenhauser C; Monecke A; Gläser C; Stadler M; Desole M; Ligeti K; Behrmann C; Müller-Tidow C; Müller LP
Transpl Infect Dis; 2014 Dec; 16(6):988-92. PubMed ID: 25179757
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
Yamashita Y; Nishikawa A; Iwahashi Y; Fujimoto M; Sasaki I; Mishima H; Kinoshita A; Hemmi H; Kanazawa N; Ohshima K; Imadome KI; Murata SI; Yoshiura KI; Kaisho T; Sonoki T; Tamura S
Int J Hematol; 2019 Jun; 109(6):744-750. PubMed ID: 30706328
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of primary hemophagocytic lymphohistiocytosis associated with perforin gene deficiency: a single-center retrospective study].
Yu MZ; Wu L; Zhang J; Wang JS; Wang YN; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):572-577. PubMed ID: 37749038
[No Abstract] [Full Text] [Related]
14. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Li Z; Wang Y; Wang J; Zhang J; Wang Z
Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
[TBL] [Abstract][Full Text] [Related]
15. Unrelated bone marrow transplantation induced long-term remission in a patient with life-threatening Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Kunitomi A; Kimura H; Ito Y; Naitoh K; Noda N; Iida H; Sao H
J Clin Exp Hematop; 2011; 51(1):57-61. PubMed ID: 21628862
[TBL] [Abstract][Full Text] [Related]
16. Difficult Balance Between EBV Treatment and Posttransplant Immunosuppression: A Successful Transplant in a Child With Recurrent Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis.
Fałkowska A; Prądzyńska K; Drabko K
Transplant Proc; 2021; 53(6):2035-2039. PubMed ID: 33933286
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
[TBL] [Abstract][Full Text] [Related]
18. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
19. HHV-8-related hemophagocytic lymphohistiocytosis in a boy with XLP phenotype.
Pasic S; Cupic M; Lazarevic I
J Pediatr Hematol Oncol; 2012 Aug; 34(6):467-71. PubMed ID: 22258354
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease.
Williams M; Afify Z
Blood; 2022 May; 139(18):2847. PubMed ID: 35511185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
